Skip to content
OpenCapital
Get started

Oscar Health OSCR AFS and Trading Securities - Unrealized Loss Position (>=12 Months)

AFS and Trading Securities - Unrealized Loss Position (>=12 Months) at other companies

CVS Health logo
CVS HealthCVS
——

Other financials

Income statement

See full
Revenue$4.6B+52.6%
Operating income$704.1M+137%
Net income$679.0M+147%
EPS (diluted)$2.07+125%

Balance sheet

See full
Cash & equivalents$4.8B+114%
Total debt$430.9M+43.7%
Total equity$1.7B+24.8%
Total assets$9.3B+59.0%

Cash flow

See full
Operating cash flow$2.6B+198%
CapEx$8.8M-2.6%
Free cash flow$2.6B+200%

Valuation

See full
Market cap$8.56B+4.0%
Enterprise value$4.16B-174%
P/S0.6×-0.2×

Profitability

See full
Operating margin0.1%—
Net margin-0.3%—
FCF margin-8.2%—

Returns & leverage

See full
Return on equity-2.6%—
Debt / equity0.3×0.0×
Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger.

The official record: Oscar Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oscar Health's afs and trading securities - unrealized loss position (>=12 months).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oscar Health's AFS and trading securities - unrealized loss position (>=12 months)?
Oscar Health (OSCR) reported AFS and trading securities - unrealized loss position (>=12 months) of $29.98M in Q1 2026.
What is the long-term trend for Oscar Health's AFS and trading securities - unrealized loss position (>=12 months)?
Over 3 years (2022 to 2025), Oscar Health's AFS and trading securities - unrealized loss position (>=12 months) has grown at a -57.1% compound annual growth rate (CAGR), from $516.09M to $40.78M.